(R)-2-(3-Fluorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride is a chiral pyrrolidine derivative featuring a 3-fluorobenzyl substituent and a carboxylic acid group, presented as its hydrochloride salt. This specific stereochemistry (R-configuration) is crucial for its biological activity and interaction with target receptors. This compound is a key intermediate in the synthesis of several pharmaceutical agents. Its primary and most documented application is in the research and development of drugs targeting the central nervous system. Specifically, it serves as a critical chiral building block for the production of novel, potent, and selective inhibitors of the glycine transporter 1 (GlyT1). GlyT1 inhibitors are a promising class of investigational drugs for the treatment of schizophrenia and other neurological disorders associated with NMDA receptor hypofunction. As a high-value synthetic intermediate, its production and supply are geared towards pharmaceutical research and process chemistry. The compound's defined chirality and functional groups make it a non-trivial synthetic target, distinguishing it from generic organic synthesis building blocks.